Cybin (HELP) Cash from Financing Activities (2020 - 2026)

Cybin (HELP) posted quarterly Cash from Financing Activities of -$169000.0 for Q1 2026, down 101.16% year-on-year from $14.6 million in Q1 2025, and down 100.12% on a QoQ basis from $143.7 million in Q4 2025.

Cybin (HELP) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Cybin (HELP) has reported Cash from Financing Activities for 7 consecutive years, with -$169000.0 the latest figure, recorded in Q1 2026.

  • Quarterly Cash from Financing Activities fell 101.16% year-over-year to -$169000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $198.2 million (up 1310.85% YoY) and the FY2026 annual result came in at $198.2 million, up 1306.45% from the prior year.
  • Cash from Financing Activities eased to -$169000.0 in Q1 2026 per HELP's latest filing, from $143.7 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for HELP reached as high as $143.7 million in Q4 2025 and fell as low as -$271000.0 in Q3 2024.
  • A 5-year average of $27.1 million and a median of $2.6 million in 2023 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2024 — Cash from Financing Activities sank 106.56% — and 2025, when it soared 112403.12%.
  • Year by year, Cash from Financing Activities stood at $2.5 million in 2022, then soared by 1045.56% to $29.2 million in 2023, then plunged by 100.44% to -$128000.0 in 2024, then surged by 112403.12% to $143.7 million in 2025, then tumbled by 100.12% to -$169000.0 in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered -$169000.0, $143.7 million, and $27000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Cybin 28.04 Mn 28.04 Mn - -169,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -169,000.00
Mar 31, 2026 -169,000.00
Dec 31, 2025 143.75 Mn
Dec 31, 2025 143.75 Mn
Sep 30, 2025 27,000.00
Sep 30, 2025 27,000.00
Jun 30, 2025 54.63 Mn
Jun 30, 2025 54.63 Mn
Mar 31, 2025 14.62 Mn
Mar 31, 2025 14.62 Mn
Dec 31, 2024 -128,000.00
Dec 31, 2024 -128,000.00
Sep 30, 2024 -271,000.00
Sep 30, 2024 -271,000.00
Jun 30, 2024 -172,000.00
Jun 30, 2024 -172,000.00
Mar 31, 2024 141.64 Mn
Mar 31, 2024 141.64 Mn
Dec 31, 2023 29.19 Mn
Dec 31, 2023 29.19 Mn